PMC:7228307 / 334-522 JSONTXT

Annnotations TAB JSON ListView MergeView

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/7228307","sourcedb":"PMC","sourceid":"7228307","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7228307","text":"atory host‐protective effector functions that are key to the normal physiology of immune resistance to pathogens. More than 100 therapeutic monoclonal antibodies (mAbs) are approved or in ","tracks":[{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T3","span":{"begin":22,"end":30},"obj":"Chemical"}],"attributes":[{"id":"A3","pred":"chebi_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/CHEBI_35224"},{"subj":"T3","pred":"source","obj":"LitCovid-PD-CHEBI"}]},{"project":"LitCovid-sample-PD-IDO","denotations":[{"id":"T2","span":{"begin":6,"end":10},"obj":"http://purl.obolibrary.org/obo/IDO_0000531"},{"id":"T3","span":{"begin":31,"end":40},"obj":"http://purl.obolibrary.org/obo/BFO_0000034"},{"id":"T4","span":{"begin":103,"end":112},"obj":"http://purl.obolibrary.org/obo/IDO_0000528"}],"attributes":[{"subj":"T2","pred":"source","obj":"LitCovid-sample-PD-IDO"},{"subj":"T3","pred":"source","obj":"LitCovid-sample-PD-IDO"},{"subj":"T4","pred":"source","obj":"LitCovid-sample-PD-IDO"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"LitCovid-PD-CHEBI","color":"#ec9e93","default":true},{"id":"LitCovid-sample-PD-IDO","color":"#93a1ec"}]}]}}